Header Logo

Connection

Naoko Takebe to Isoxazoles

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Isoxazoles.
Naoko Takebe
Connection Strength
0.061
Isoxazoles
  1. Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors. JCO Precis Oncol. 2025 Jul; 9:e2500055.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.